Credit Suisse analyst Charles Brennan maintained a Neutral rating on Accenture and raised his price target to $170 from $160 following the company's "solid" Q4 report. In a research note to investors, Brennan notes that while current momentum is strong, the announced FY19 revenue guidance is for 5%-8% growth, and while investors will assume the company will hit the high end of this range, "it is hard to see" how the shares can materially re-rate on this basis with management allowing for some macro risks.
IBM (IBM) is scheduled to report results of its fiscal first quarter after the market close on April 24, with a conference call scheduled for 5:00 pm ET. What to watch... To see the rest of the story go to thefly.com. See Story Here